InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PYX | Ann:PYX Awarded Modified Licence to Export Rutile (Price Sensitive) | 17/09/24 | 0 | 1 | |||
|
|||||||
PYX | Ann:PYX Receives Two-Year Licence (Price Sensitive) | 09/02/24 | 0 | 1 | |||
|
|||||||
PYX | Ann:Operational Results FY 2023 (Price Sensitive) | 09/02/24 | 0 | 1 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||